Health News: [cancer]

Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer PR Newswire via Yahoo! Finance Fri, 25 Mar 2011 06:00 AM PDT Mersana Therapeutics today announced  the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer.  The study will be carried out in 10 clinical centers in the US.  The Phase 1b follows the ... Image-Guided Radiotherapy System aids cancer treatment. ThomasNet Fri, 25 Mar 2011 05:59 AM PDT TrueBeam(TM) treats tumors, including those that move during treatment as patient breathes in/out, in image-guided radiotherapy and radiosurgery applications. Integrated technologies dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. Specific areas of use include treatment of lung, breast, prostate, head, neck, and other types of cancer. This story ... Donation will make cancer journey a little easier North Platte Telegraph Fri, 25 Mar 2011 05:56 AM PDT The North Platte Telegraph Hearing the word "cancer" from someone within your circle of friends and family is a life-altering experience. It only takes a visit to the annual Relay for Life ceremony to understand just how much cancer impacts this community. Mt. Laurel church to hold fundraiser for cancer patient Medford Central Record Fri, 25 Mar 2011 05:55 AM PDT She has more faith sick than most people have when they’re well. And sick doesn’t even describe what she’s gone through for the last year. Lesia Longacre has had a bone marrow transplant and many rounds of chemotherapy, all in the hopes of stopping the acute myeloid leukemia that has racked her body. UCLA's cancer 'roadmap' could help combat resistance to targeted drug therapies EurekAlert! Fri, 25 Mar 2011 05:53 AM PDT ( University of California - Los Angeles ) Researchers demonstrate their use of network-scale proteomic experiments and mathematical analyses to build a "system-wide" (systems biology) view of how signaling mutations cause leukemia and to identify points of susceptibility that can be targeted by cocktail therapy approaches to prevent drug resistance. Gift of Hope gets donation North Platte Telegraph Fri, 25 Mar 2011 05:52 AM PDT The North Platte Telegraph Life throws plenty of daily complications our way. For those dealing with cancer, those complications can mean the difference between paying the electric bill and being able to buy pain medication. NPHS alumna offers hope to kids with cancer North Platte Telegraph Fri, 25 Mar 2011 05:45 AM PDT The North Platte Telegraph Janice Olson's mother thought her daughter's achievement of curing children with cancer was something worth recognition. The North Platte Distinguished Alumni Selection Committee seconded Alice Olson's feeling. Janice will be honored at the North Platte Public School Foundation's Education After Hours event on April 1. She is one of three who will be honored, along ... Broncos rally: WMU hockey players take 3-year-old cancer patient, brother 'under our wing' (with video) The Kalamazoo Gazette Fri, 25 Mar 2011 05:44 AM PDT "It's given us something to watch and believe in. It's changed our lives." Emory Explores New Proton Therapy Facility To Offer Advanced Care To Cancer Patients Medical News Today Fri, 25 Mar 2011 05:44 AM PDT Emory Healthcare is a key player in plans to bring the world's most advanced radiation treatment for cancer patients to Georgia. In furtherance of that role, Emory Healthcare has signed a letter of intent with Advanced Particle Therapy, LLC, of Minden, Nevada, opening the door to a final exploratory phase for development of The Georgia Proton Treatment Center - Georgia's first proton therapy ... Early Detection And Prognosis Of Cancer Improved By New Technology Medical News Today Fri, 25 Mar 2011 05:43 AM PDT Gentel Biosciences, a leader in proteomics tools, and Van Andel Research Institute (VARI), a biomedical research institute, have jointly announced the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide. Gentel first obtained an exclusive right to commercialize the technology in 2006. According ...

See more health stories that match my keyword Visit Yahoo! Health

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.